A Study of AA4500 in Men With Peyronie's Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

348

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Peyronie's Disease
Interventions
BIOLOGICAL

AA4500

2 injections separated by at least 24 hours but not more than 72 hours, repeated after 42 days (± 5 days) for up to 4 treatment cycles (ie, total of up to 8 injections per subject)

Trial Locations (39)

3140

Tauranga Urology Research Ltd., Tauranga

6021

Wellington Urology Associates, Wellington South

8011

Primorus Clinical Trials Ltd., Christchurch

8014

CURT Medical Trials Trust Board Inc., Christchurch

10016

University Urology Associates, New York

11219

Maimonides Medical Center, Division of Urology, Brooklyn

19004

Urologic Consultants of SE PA, Bala-Cynwyd

23235

Virginia Urology, Richmond

23502

Urology of Virginia-Sentara Medical Group, Norfolk

33180

South Florida Medical Research, Aventura

45212

Tristate Urologic Services PSC, Inc./ dba TUG Research, Cincinnati

46825

Northeast Indiana Research, LLC, Fort Wayne

47130

Metropolitan Urology, P.S.C., Jeffersonville

60612

Urology Specialists, S.C., Chicago

91505

Urology Associates Medical Group, Burbank

06762

Connecticut Clinical Research Center, LLC, Middlebury

06511

The Urology Center, P.C., New Haven

DK-9100

Aarhus Universitiy Hospital, Aalborg Sygehus, Aalborg

DK-2000

Frederiksberg Hospital, Frederiksberg

DK-3600

Frederikssunds Hospital, Frederikssund

DK-2820

Klinik for seksuelle dysfunktioner, Gentofte Municipality

F-69 437

Centre Hospitalier Edouar Herriot, Lyon

F-69230

Hopital Henri Gabrielle, Saint-Genis-Laval

DE-79106

Universitatsklinikum Freiburg, Abteilung Urologie, Freiburg im Breisgau

DE-20354

Private Practice of Urology/Andrology, Hamburg

DE-35039

Uro-Onkologische Praxis Dr. von Keitz, Marburg

DE-72764

Urologische Gemeinschaftspraxis Reutlingen, Reutlingen

DE-72096

Universitatsklinikum Tubingen, Tübingen

I-80131

"University of Naples Federico II", Naples

I-00133

Universitiy Tor Vergatat of Rome, Rome

0622

Waitemata Urology Research North Shore Hospital, Takapuna

0112

Cardinal Points Research Ltd., Whangarei

ES-08036

Hospital Clinic de Barcelona, Barcelona

ES-28043

Hospital La Zarzuela, Madrid

SE-405 45

Specialistmottagningen i urologi, Gothenburg

SE-374 35

Carlshamns Specialistklinik, Karlshamn

SE-751 85

Akademiska Sjukhuse, Uppsala

W1G 6BJ

St. Peter's Andrology Centre, London

SR4 &TP

Sunderland Royal Hospital, Sunderland

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY